Growing community of inventors

Nagoya, Japan

Hitoshi Hishida

Average Co-Inventor Count = 16.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Hitoshi HishidaYuichi Ishikawa (2 patents)Hitoshi HishidaYasushi Saito (2 patents)Hitoshi HishidaYuji Matsuzawa (2 patents)Hitoshi HishidaMasunori Matsuzaki (2 patents)Hitoshi HishidaHideki Origasa (2 patents)Hitoshi HishidaMitsuhiro Yokoyama (2 patents)Hitoshi HishidaToru Kita (2 patents)Hitoshi HishidaHiroshige Itakura (2 patents)Hitoshi HishidaShinichi Oikawa (2 patents)Hitoshi HishidaJun Sasaki (2 patents)Hitoshi HishidaAkira Kitabatake (2 patents)Hitoshi HishidaNoriaki Nakaya (2 patents)Hitoshi HishidaToshiie Sakata (2 patents)Hitoshi HishidaKazuyuki Shimada (2 patents)Hitoshi HishidaKunio Shirato (2 patents)Hitoshi HishidaYuichi Ishikawa (1 patent)Hitoshi HishidaYuji Matsuzawa (0 patent)Hitoshi HishidaHitoshi Hishida (2 patents)Yuichi IshikawaYuichi Ishikawa (72 patents)Yasushi SaitoYasushi Saito (37 patents)Yuji MatsuzawaYuji Matsuzawa (21 patents)Masunori MatsuzakiMasunori Matsuzaki (14 patents)Hideki OrigasaHideki Origasa (11 patents)Mitsuhiro YokoyamaMitsuhiro Yokoyama (11 patents)Toru KitaToru Kita (5 patents)Hiroshige ItakuraHiroshige Itakura (5 patents)Shinichi OikawaShinichi Oikawa (3 patents)Jun SasakiJun Sasaki (2 patents)Akira KitabatakeAkira Kitabatake (2 patents)Noriaki NakayaNoriaki Nakaya (2 patents)Toshiie SakataToshiie Sakata (2 patents)Kazuyuki ShimadaKazuyuki Shimada (2 patents)Kunio ShiratoKunio Shirato (2 patents)Yuichi IshikawaYuichi Ishikawa (2 patents)Yuji MatsuzawaYuji Matsuzawa (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Mochida Pharmaceutical Co., Ltd. (2 from 227 patents)


2 patents:

1. 9198892 - Composition and/or method for preventing onset and/or recurrence of cardiovascular events

2. 8367725 - Composition and/or method for preventing onset and/or recurrence of cardiovascular events

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…